These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 22583896)

  • 21. A combination of (ω-3) polyunsaturated fatty acids, polyphenols and L-carnitine reduces the plasma lipid levels and increases the expression of genes involved in fatty acid oxidation in human peripheral blood mononuclear cells and HepG2 cells.
    Radler U; Stangl H; Lechner S; Lienbacher G; Krepp R; Zeller E; Brachinger M; Eller-Berndl D; Fischer A; Anzur C; Schoerg G; Mascher D; Laschan C; Anderwald C; Lohninger A
    Ann Nutr Metab; 2011; 58(2):133-40. PubMed ID: 21540583
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis.
    Larter CZ; Yeh MM; Van Rooyen DM; Brooling J; Ghatora K; Farrell GC
    J Gastroenterol Hepatol; 2012 Feb; 27(2):341-50. PubMed ID: 21929649
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selectivity of fatty acid ligands for PPARalpha which correlates both with binding to cis-element and DNA binding-independent transactivity in Caco-2 cells.
    Mochizuki K; Suruga K; Fukami H; Kiso Y; Takase S; Goda T
    Life Sci; 2006 Dec; 80(2):140-5. PubMed ID: 17007889
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Macrophage expression of peroxisome proliferator-activated receptor-alpha reduces atherosclerosis in low-density lipoprotein receptor-deficient mice.
    Babaev VR; Ishiguro H; Ding L; Yancey PG; Dove DE; Kovacs WJ; Semenkovich CF; Fazio S; Linton MF
    Circulation; 2007 Sep; 116(12):1404-12. PubMed ID: 17724261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of peroxisome proliferator-activated receptor alpha by dietary fish oil attenuates steatosis, but does not prevent experimental steatohepatitis because of hepatic lipoperoxide accumulation.
    Larter CZ; Yeh MM; Cheng J; Williams J; Brown S; dela Pena A; Bell-Anderson KS; Farrell GC
    J Gastroenterol Hepatol; 2008 Feb; 23(2):267-75. PubMed ID: 17868330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential effects of in vivo PPAR alpha and gamma activation on fatty acid transport proteins expression and lipid content in rat liver.
    Wierzbicki M; Chabowski A; Zendzian-Piotrowska M; Gorski J
    J Physiol Pharmacol; 2009 Mar; 60(1):99-106. PubMed ID: 19439812
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 4',6-Dimethoxyisoflavone-7-O-β-D-glucopyranoside (wistin) is a peroxisome proliferator-activated receptor α (PPARα) agonist in mouse hepatocytes.
    Suzuki M; Nakamura F; Taguchi E; Nakata M; Wada F; Takihi M; Inoue T; Ohta S; Kawachi H
    Mol Cell Biochem; 2018 Sep; 446(1-2):35-41. PubMed ID: 29318455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. C333H, a novel PPARalpha/gamma dual agonist, has beneficial effects on insulin resistance and lipid metabolism.
    Xu C; Wang LL; Liu HY; Zhou XB; Cao YL; Li S
    Acta Pharmacol Sin; 2006 Feb; 27(2):223-8. PubMed ID: 16412273
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimization of an enzyme-linked immunosorbent assay to screen ligand of Peroxisome proliferator-activated receptor alpha.
    Cho MC; Lee S; Choi HS; Yang Y; Tae Hong J; Kim SJ; Yoon DY
    Immunopharmacol Immunotoxicol; 2009; 31(3):459-67. PubMed ID: 19263263
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peroxisome proliferator-activated receptor alpha is involved in the regulation of lipid metabolism by ginseng.
    Yoon M; Lee H; Jeong S; Kim JJ; Nicol CJ; Nam KW; Kim M; Cho BG; Oh GT
    Br J Pharmacol; 2003 Apr; 138(7):1295-302. PubMed ID: 12711630
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diminished hepatocellular proliferation in mice humanized for the nuclear receptor peroxisome proliferator-activated receptor alpha.
    Cheung C; Akiyama TE; Ward JM; Nicol CJ; Feigenbaum L; Vinson C; Gonzalez FJ
    Cancer Res; 2004 Jun; 64(11):3849-54. PubMed ID: 15172993
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peroxisome proliferator-activated receptor (PPAR) alpha and PPARbeta/delta, but not PPARgamma, modulate the expression of genes involved in cardiac lipid metabolism.
    Gilde AJ; van der Lee KA; Willemsen PH; Chinetti G; van der Leij FR; van der Vusse GJ; Staels B; van Bilsen M
    Circ Res; 2003 Mar; 92(5):518-24. PubMed ID: 12600885
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma mannose-binding lectin is stimulated by PPARα in humans.
    Rakhshandehroo M; Stienstra R; de Wit NJ; Bragt MC; Haluzik M; Mensink RP; Müller M; Kersten S
    Am J Physiol Endocrinol Metab; 2012 Mar; 302(5):E595-602. PubMed ID: 22215653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peroxisome proliferator-activated receptor alpha activation induces unfavourable changes in fatty acid composition of myocardial phospholipids.
    Baranowski M; Blachnio-Zabielska A; Gorski J
    J Physiol Pharmacol; 2009 Jun; 60(2):13-20. PubMed ID: 19617640
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-chain fatty acid effects on peroxisome proliferator-activated receptor-alpha-regulated genes in Madin-Darby bovine kidney cells: optimization of culture conditions using palmitate.
    Thering BJ; Bionaz M; Loor JJ
    J Dairy Sci; 2009 May; 92(5):2027-37. PubMed ID: 19389960
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of linoleate on cell viability and lipid metabolic homeostasis in goose primary hepatocytes.
    Pan Z; Wang J; Tang H; Li L; Lv J; Han C; Xia L; Xu F
    Comp Biochem Physiol A Mol Integr Physiol; 2011 Jun; 159(2):113-8. PubMed ID: 21295151
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peroxisome proliferator-activated receptor alpha activation regulates lipid metabolism in the feto-placental unit from diabetic rats.
    Martínez N; Capobianco E; White V; Pustovrh MC; Higa R; Jawerbaum A
    Reproduction; 2008 Jul; 136(1):95-103. PubMed ID: 18417641
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular mechanisms of alcoholic fatty liver: role of peroxisome proliferator-activated receptor alpha.
    Crabb DW; Galli A; Fischer M; You M
    Alcohol; 2004 Aug; 34(1):35-8. PubMed ID: 15670663
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of the hepatic fatty acid pool in peroxisomal 3-ketoacyl-CoA thiolase B-null mice exposed to the selective PPARalpha agonist Wy14,643.
    Arnauld S; Fidaleo M; Clémencet MC; Chevillard G; Athias A; Gresti J; Wanders RJ; Latruffe N; Nicolas-Francès V; Mandard S
    Biochimie; 2009; 91(11-12):1376-86. PubMed ID: 19772884
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of miRNA-10b in regulating cellular steatosis level by targeting PPAR-alpha expression, a novel mechanism for the pathogenesis of NAFLD.
    Zheng L; Lv GC; Sheng J; Yang YD
    J Gastroenterol Hepatol; 2010 Jan; 25(1):156-63. PubMed ID: 19780876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.